OR WAIT null SECS
© 2021 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
July 29, 2021
Thermo Fisher Scientific has added a new suite of immune repertoire assays that offers high detection rates of malignant clones, allowing researchers to better assess blood cancers.
July 08, 2021
A new media panel, gene kit, and advanced resins that are now in Thermo Fisher Scientific’s gene therapy portfolio aim to reduce manufacturing costs and increase gene therapy viability.
LGM Pharma will offer contract analytical testing and stability services to pharmaceutical developers and manufacturers.
July 03, 2021
The ever-increasing complexity of biotherapeutic molecules presents unique analytical challenges for developers.
The future pipeline of complex novel biotherapeutics will require new approaches to analytical assessment.
July 01, 2021
Developing bioassay methods requires a new approach for cell and gene therapy drug development.
June 30, 2021
Chalmers University researchers have developed a method to label and track mRNA molecules.
June 02, 2021
Outsourcing method development offers multiple benefits to companies, including access to experience and expertise, streamlined costs, and development time efficiencies.
May 16, 2021
The sensitivity of droplet digital PCR helps manufacturers detect Mycoplasma contamination in AAV-based gene therapy products.
May 02, 2021
Mass spectrometry and automation are growing in importance for protein characterization, but further improvements are still needed.